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Abstract
Background: Enhanced production of nitric oxide (NO) following upmodulation of the inducible isoform of NO
synthase (iNOS) by haemozoin (HZ), inflammatory cytokines and LPS may provide protection against Plasmodium
falciparum malaria by killing hepatic and blood forms of parasites and inhibiting the cytoadherence of parasitized
erythrocytes (RBC) to endothelial cells. Monocytes and macrophages are considered to contribute importantly
to protective upregulation of iNOS and production of NO. Data obtained with murine phagocytes fed with human
HZ and synthetic HZ (sHZ) indicate that supplemental treatment of those cells with IFN-gamma elicited
significant increases in protein and mRNA expression of iNOS and NO production, providing a potential
mechanism linking HZ phagocytosis and increased production of NO. Purpose of this study was to analyse the
effect of P. falciparum HZ and sHZ supplemental to treatment with IFN-gamma and/or a stimulatory cytokine-LPS
mix on iNOS protein and mRNA expression in immuno-purified human monocytes.
Methods: Adherent immunopurified human monocytes (purity >85%), and murine phagocytic cell lines RAW
264.7, N11 and ANA1 were fed or not with P. falciparum HZ or sHZ and treated or not with IFN-gamma or a
stimulatory cytokine-LPS mix. Production of NO was quantified in supernatants, iNOS protein and mRNA
expression were measured after immunoprecipitation and Western blotting and quantitative RT-PCT,
respectively.
Results: Phagocytosis of HZ/sHZ by human monocytes did not increase iNOS protein and mRNA expression
and NO production either after stimulation by IFN-gamma or the cytokine-LPS mix. By contrast, in HZ/sHZ-laden
murine macrophages, identical treatment with IFN-gamma and the cytokine-LPS mix elicited significant increases
in protein and mRNA expression of iNOS and NOS metabolites production, in agreement with literature data.
Conclusion: Results indicate that human monocytes fed or not with HZ/sHZ were constantly unable to express
iNOS and generate NOS metabolites even after stimulation with IFN-gamma or a cytokine-LSP mix that were
very active on HZ-fed murine phagocytic lines. Present data do not support the hypothesis that monocytes are
mediators of anti-parasitic defence in clinical malaria via activation of iNOS and production of NO, and suggest
caution in extrapolating data obtained with murine or hybrid systems to human malaria.
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Background
Nitric oxide (NO) is a potent free radical produced by
nitric oxide synthase (NOS) [1,2]. Activity of inducible
NOS (iNOS), the high-output, cytokine-modulated iso-
form of NOS varies very widely in different species and
cell types [3]. In humans, endothelia, hepatocytes and
smooth muscle cells are the major contributing cells,
while monocytes/macrophages appear to produce no or
little NO in response to IFN-gamma, TNF-alpha, or IL-
1beta [3-6], highly effective stimuli in murine macro-
phages [7]. Data indicate that severe murine and human
malaria is accompanied by increased iNOS activity and
production of NO [8,9], considered to be beneficial
because NO was shown to kill parasites [10,11]. Secondly,
elevated NO levels in the blood of malaria patients were
associated with inhibition of adhesion of parasites to
endothelia [12]. Increased NO levels and protection
against malaria have been linked to a single nucleotide
polymorphism in the promoter of iNOS gene termed
NOS2Lambaréné (G-954C) mutation [13]. Blood monocytes
of those protected heterozygotes had a 7-fold higher base-
line iNOS activity [13]. Recently, it has been shown that
phagocytosis of P. falciparum haemozoin (HZ) and syn-
thetic HZ (sHZ, beta-haematin) by murine phagocytes sig-
nificantly increased IFN-gamma-mediated iNOS
expression and NO production [14], offering a mechanis-
tic link to the increased, possibly protective NO levels
observed in clinical malaria. Here the authors analysed
iNOS mRNA, protein expression and NO production in
HZ/sHZ-fed immuno-purified human monocytes and
were unable to find any iNOS expression and NO produc-
tion even after maximal stimulation by IFN-gamma, TNF-
alpha, IL-1beta and LPS, whereas these stimuli were
highly effective in HZ-laden murine phagocytes. Lack of
iNOS response by human monocytes shown here casts
doubt on the capacity of those cells to produce NO in vivo
and mediate protection in clinical malaria, and suggests
caution in transferring data obtained with non-human
cells to human malaria.
Methods
Materials
Unless otherwise stated, reagents were from Sigma Chem
Co, St Louis, MO; cell culture supplements were from Inv-
itrogen, Carlsbad, CA.
Culture of P. falciparum and isolation of native HZ
P. falciparum parasites (Palo Alto strain, mycoplasma-free)
were kept in culture as described [15]. HZ was harvested
from synchronous cultures at ring stage, 12 h after infec-
tion of RBCs added to separated schizonts. To avoid con-
tamination with schizont debris, HZ was collected from
the 10–40% interphase after centrifugation at 5,000 g on
a discontinuous Percoll-mannitol density gradient. HZ
was washed at 4°C 5 times with 10 mM phosphate buffer,
pH 8.0, containing 10 mM mannitol and once with phos-
phate buffered saline (PBS), pH 7.4, and stored at -20°C
at 20% (vol/vol) in PBS. Native HZ used in this study cor-
responds closely to the material phagocytosed in vivo by
human phagocytes.
Preparation of beta-haematin (synthetic HZ, sHZ) and 
haemin
sHZ was synthesized according to the Slater et al. proce-
dure [16] modified as follows. Haemin chloride (380 mg)
was dissolved in 80 mL of 0.1 M NaOH and haem precip-
itated by addition of 28 mL glacial acetic acid for 12 h at
80°C. Crystalline sHZ was washed four times with milliQ
water, four times for 3 h and two times for 1 h with 100
mM sodium bicarbonate at pH 9.1, in order to fully
remove free haem, and finally four times with milliQ
water. Remaining insoluble sHZ was washed once with
PBS 1:5 (vol/vol), resuspended in PBS 1:5 (vol/vol) and
stored at 4°C. Haemin (monomeric haem) was added to
the adherent cells as met-haem-albumin, containing 2.5
mM haemin in 10 mM Tris, pH 7.5, 1.25% albumin and
100 mM NaCl. The solution was filtered through a 0.2-
µm-pore filter before adding to the cells.
Opsonization of HZ and sHZ
Immediately before phagocytosis HZ and sHZ were
washed in PBS, finely dispersed in PBS at 30% (vol/vol)
and added to the same volume of freshly prepared human
A-serum. After 30-min incubation at 37°C, opsonization
was terminated by one washing in PBS immediately
before addition to adherent cells.
Immuno-purified human monocytes
Monocytes were isolated from freshly discarded buffy
coats from peripheral blood of healthy Italian donors by
Ficoll centrifugation and purified by immuno-depletion
of lymphocytes with Dynabeads M-450 CD2 Pan T and
M-450 CD19 Pan B (Dynal, Oslo, Norway) as described
[15]. By this method monocytes were 86.7 ± 3.7% pure
(mean ± SE, n = 5), as judged from physical parameters
and the expression of monocytic surface antigens (CD14+,
MHC class I and II) evaluated by cytofluorimetry. The
contaminating cells (approx. 14%) were CD2-negative/
CD3-positive cells unable to bind to the beads to allow
immunomagnetic separation. The number of iNOS-
expressing NK-cells was negligible. To the best of our
knowledge, there is no evidence that "contaminating"
lymphocytes express iNOS or interfere with iNOS-expres-
sion in human monocytes. Abs used were: anti-CD14
(3C10; American Type Culture Collection (ATCC), Man-
assas, VA), anti MHC class I (W6.32, ATCC) and anti-
MHC class II (BT-2.9, [17]). The immuno-purification
provided higher yields of pure monocytes compared to
purification by cytoadherence to plastics. Based on the
same quality criteria as above, adherence-purified mono-Malaria Journal 2007, 6:73 http://www.malariajournal.com/content/6/1/73
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cytes, analysed within 12 h from plating, were 34.2 ±
3.0% pure (mean ± SE, n = 19). Monocytes, resuspended
at 1 × 106 and 5.0 × 106 cells per mL to obtain non-conflu-
ent and confluent cell condition, respectively, were plated
in 35 mm-diameter culture dishes. Cells were kept either
in RPMI 1640 cell culture medium, supplemented with L-
glutamine, sodium pyruvate, non-essential amino acids
and 10% (vol/vol) foetal calf serum (RS-FCS) or in mac-
rophage serum-free medium (M-SFM). After 30 min incu-
bation at 37°C dishes were washed three times with RPMI
1640 to remove non-adherent cells. Two mL of RS-FCS or
M-SFM were added to each dish and phagocytosis and
cytokine treatment were immediately started, as described
below. Cells seeded at different densities in different
media gave similar results. Adherent monocytes kept in
M-SFM for two days before starting experiments showed
same results as freshly plated cells. Results described here
were obtained with 1 × 107 cells/dish in M-SFM plated on
the day of experiment.
Murine phagocytic cell lines
Cells of the murine phagocytic cell lines ANA1 and RAW
264.7 [18,19] and the murine microglial phagocytic
monocytic cell line N11 [20] were plated at 5.0 × 106 cells
(confluent cells condition) per mL RPMI 1640, contain-
ing 10% FCS, in 35 mm-diameter culture dishes and incu-
bated for 24 h before starting phagocytosis and cytokine
treatment as described before. The 24 h period after plat-
ing was shown to be adequate for efficient induction of
iNOS.
Phagocytosis and cytokine treatment of cells
Phagocytosis was started by adding opsonized HZ or
opsonized sHZ at 50 RBC equivalents in terms of haem
content per cell to adherent human monocytes or RAW
264.7, ANA1, and N11 murine cells. Alternatively, cells
were treated with 100 µM haemin or remained untreated
as controls. Portions of the phagocytosing and control
cells were stimulated with 100 U/mL IFN-gamma (human
recombinant, R&D, Minneapolis, MN, USA) at the begin-
ning of phagocytosis. Maximal iNOS stimulation was elic-
ited by treating cells with the stimulatory cytokine-LPS
mix containing 400 U/mL IFN-gamma (R&D), 500 U/mL
TNF-alpha (human recombinant, PreproTech, Rocky Hill,
NJ), 100 U/mL IL-1beta (human recombinant, Prepro-
Tech) and 20 µg/mL LPS (from Escherichia coli 055:B5,
Sigma) (final concentrations). After 24 h incubation,
supernatants were collected for assessment of NO produc-
tion. The cells were washed three times with PBS and used
in immunoprecipitation, Western blotting and mRNA
studies.
Viability and cytokine response of isolated monocytes
Cell apoptosis was assayed by Annexin-V binding evalu-
ated by cytofluorimetry according to manufacturer's spec-
ifications (Alexis Biochemicals, Lausen, Switzerland).
Additionally, cell death was excluded by propidium
iodide staining performed according to the manufac-
turer's instructions. Expression of the cytokine-responsive
membrane antigens MHC class II and CD54 was tested
after exposure of cells to IFN-gamma and the cytokine-LPS
mix [15]. Labeling and subsequent phenotypic analysis by
cytofluorimetry of monocytes was performed on day 1
and 2 after cell plating. Monoclonal Abs were: anti-CD54
(Serotec, Oxford, U.K.) and anti-MHC class II (BT-2.9
hybridome [17]. Bound antibodies were revealed by FITC-
conjugated F(ab') goat anti-mouse IgG. Mean fluores-
cence intensity (MFI) was measured and data analysed
using a FACScan cytofluorograph (Becton Dickinson,
Sunnyvale, CA) and CellQuest software.
Analysis of signal transduction by the IFN-gamma 
receptor. Phosphorylation of JAK-2 after IFN-gamma 
stimulation
Adherent control and HZ-fed immuno-purified human
monocytes were washed and harvested in ice-cold PBS,
containing 20 mM mannitol 24 h after phagocytosis. After
10-min preincubation in PBS containing 1 mM ortho-
vanadate, cells were treated with 500 U/mL IFN-gamma
for 5 min on ice. Cells were lysed in 50 mM Tris-buffer,
pH 7.4, containing 150 mM NaCl, 1% Triton X-100, 1
mM ortho-vanadate and complete protease inhibitor
cocktail (Roche, Mannheim, Germany). Phosphorylated
lysate proteins from 20 × 106 monocytes were immuno-
precipitated by sequential treatment with a monoclonal
anti-phosphotyrosine antibody (clone G410, Upstate Bio-
technology, Lake Placid, NY) and anti-mouse IgG-agar-
ose. Immunoprecipitates were separated in a 7%
acrylamide SDS-PAGE, transferred to nitrocellulose mem-
branes and probed with a rabbit polyclonal anti-JAK-2
antibody (Upstate Biotechnology). Enhanced chemilumi-
nescence was used for detection of phosphorylated JAK-2.
NO quantification in cell culture supernatants
Production of NO was assessed by measuring the accumu-
lation of nitrite in the cell culture supernatants by the
Griess reaction as described [21]. Briefly, 150 µL of centri-
fuged cell supernatants were mixed with the same volume
of Griess reagent and the absorbance quantified at 550
nm with a Benchmark Plus plate reader (Bio-Rad Labora-
tories, Hercules, CA), using the Microplate Manager 5.2
software (Bio-Rad). Nitrite dissolved in the different
media was used to generate standard curves for each plate
reading. Protein concentration in cell lysates in each sam-
ple was assayed using the Bio-Rad protein assay according
to the manufacturer's instructions.
Immunoprecipitation of iNOS
Washed human monocytes and murine phagocytic cell
lines were supplemented with complete protease inhibi-Malaria Journal 2007, 6:73 http://www.malariajournal.com/content/6/1/73
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tor cocktail (Roche) and 5 mM N-ethylmaleimide, har-
vested and lysed for 10 min at 4°C in 20 mM Tris-buffer,
pH 7.4, containing 150 mM NaCl, 1% (wt/vol) SDS,
Complete protease inhibitor cocktail (Roche) and 1 mM
ortho-vanadate. The lysate was centrifuged and the super-
natant protein concentration adjusted to 1 mg/mL of the
immune-precipitation (IP) buffer, composed of 10 mM
Tris-buffer, pH 7.4, 1% (vol/vol) Triton X-100, 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 0.2 mM ortho-vanadate,
0.2 mM PMSF, 0.5% (vol/vol) NP-40 (final concentra-
tions). Monoclonal anti-iNOS antibody (BD Transduc-
tion Laboratories, Lexington, KY, USA) was added at a
final dilution of 1:500 for 12 h at 4°C. Antibody-bound
iNOS was precipitated with anti-mouse IgG-agarose (20
µL/mL, final concentration) added for 2.5 h at 4°C and
sedimented by centrifugation. After three washes with IP-
buffer the immune-precipitated proteins were solubilized
in SDS-sample buffer for 3 min at 95°C and frozen until
use for SDS-PAGE and subsequent Western blotting.
Western blotting of iNOS
Washed human monocytes and murine phagocytic cell
lines were supplemented with Complete protease inhibi-
tor cocktail (Roche) and 5 mM N-ethylmaleimide. Cells
were then lysed in cold SDS-Sample Buffer and lysate pro-
teins (20 µg) or immunoprecipitated proteins (originat-
ing from 500 µg lysate protein) were subjected to SDS-
PAGE, 10% acrylamide (wt/vol), and separated proteins
were transferred onto a polyvinylidene difluoride mem-
brane (PVDF; Millipore, Bedford, MA). After the transfer
the membrane was rinsed in methanol for 20 s, and than
incubated with monoclonal mouse anti-iNOS antibody
(BD Transduction Laboratories) in PBS with 1% (wt/vol)
BSA for 1 h. Proteins were detected with an anti-mouse
HRP-conjugated sheep antibody (Amersham Biosciences,
Buckinghamshire, UK) and visualized subsequently by
ECL. Recombinant iNOS (Sigma) was used as positive
control.
RT-PCR studies
The expression of human and murine iNOS mRNA was
analysed by quantitative real-time RT-PCR and qualitative
RT-PCR. Total cellular RNA was quantitatively isolated
from washed human monocytes and murine phagocytic
cell lines using Standard RNA Releaser, RNA specific resin
and elution solution (RNA Extraction Kit, Nurex, Sassari,
Italy) following the manufacturer's specifications. Subse-
quently, the RNA was reverse-transcribed using Moloney
murine leukemia virus reverse transcriptase (7.7 U/µL
final concentration; Invitrogen) and oligo-dT (11.5 µg/µL
final concentration; Invitrogen). PCR was performed
using cDNA from 50,000 cells with primer pairs specific
for iNOS.
Quantitative real-time RT-PCR
For human iNOS two different primer pairs were used.
The first one was 5'-CAGCGGGATGACTTTCCAA-3' and
5'-AGGCAAGATTTGGACCTGCA-3' [22,23]. The second
one was 5'-AGCGGGATGACTTTCCAAGA-3' and 5'-TAAT-
GGACCCCAGGCAAGATT-3' [24]. GAPDH intron over-
lappingprimers were from the Bio-Rad library (Bio-Rad).
Murine iNOS primer pair was 5'-TGCCCCTTCAATGGTT-
GGTA and 5'-ACTGGAGGGACCAGCCAAAT-3'. Murine
beta-actin primers were 5'-TCACCCACACTGTGCCCATC-
TACGA-3' and 5'-GGATGCCACAGGATTCCATACCCA-3'
[18]. For each 50 µL real-time RT-PCR reaction mix, 2.0 µL
cDNA (corresponding to 50,000 cells), 1.0 µL sense and
anti-sense primer (both 10 µM; Invitrogen), 1.0 µL dNTP
(10 mM; Applied Biosystem, Foster City, CA), 3.0 µL
MgCl2 (50 mM), 2.5 U Platinum Taq DNA Polymerase
(Invitrogen), 5.0 µL Buffer (10×), 3.25 µL SYBR Green
(final dilution 1:10,000), and 33.25 µL PCR-grade water
were mixed. After denaturation for 2 min at 94°C, RT-PCR
assays were carried out for 50 cycles with denaturation for
30 s at 94°C, annealing for 30 s at 60°C, and extension for
30 s at 72°C. The specified mode of reaction was control-
led with the melting curve. Real-time RT-PCR analyses
were performed with the iCycler iQ real-time RT-PCR
detection system (Bio-Rad).
Qualitative RT-PCR
Qualitative RT-PCR was performed with MyCycler detec-
tion system (Bio-Rad) with the same reaction mix and
temperature conditions used for real-time RT-PCR. For
murine iNOS primers were 5'-GGAGATCAATGTGGCT-
GTGC-3' and 5'-AAGGCCAAACACAGCATACC-3' (631
bp); primers for β-actin were 5'-GGTCATCTTCTCGCG-
GTTGGCCTTGGGGT-3' and 5'-CCCCAGGCACCAG-
GGCGTGAT-3' (230 bp) [20].
Statistical analysis
Data are presented as mean ± standard error of the mean
(SE). Statistical significance was analysed using two-sam-
ple t-test.
Results
Viability and cytokine response of immuno-purified human 
monocytes
Monocytes viability was tested by Annexin-V binding. The
percentage of AnnexinV-binding-cells (considered to be
apoptotic) was negligible during the experimental period
and never higher than 4% at 48 h after plating in control,
HZ or sHZ-fed and IFN-gamma and cytokine-LPS mix-
treated monocytes. The percentage of dead cells positive
to propidium iodide staining was lower than 2%. Human
monocytes respond to stimulation by LPS, IFN-gamma
and inflammatory cytokines with upregulation of mem-
brane expression of CD54 (ICAM 1) and MHC class II
[15,25]. Ability of immuno-purified human monocytesMalaria Journal 2007, 6:73 http://www.malariajournal.com/content/6/1/73
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(purity >85%) to respond to LPS and inflammatory
cytokines was tested after treatment with IFN-gamma
(100 U/mL) or a cytokine-LPS mix containing IFN-
gamma (400 U/mL), TNF-alpha (500 U/mL), IL-1beta
(100 U/mL) and LPS (20 µg/mL) (final concentrations).
Monocytes were responsive to cytokines, as membrane
expression of CD54 (ICAM 1) and MHC class II was pro-
gressively increased at 24 and 48 h after start of treatment.
At 48 h, stimulation by IFN-gamma or cytokine-LPS mix
increased surface expression of CD54 1.4 ± 0.1-fold and
1.8 ± 0.5-fold (n = 5), respectively, and surface expression
of MHC class II 1.9 ± 0.4-fold and 2.2 ± 0.4-fold (n = 5),
respectively (Figure 1). HZ-fed monocytes were shown to
be less responsive to IFN-gamma in terms of increased
expression of surface antigen [15]. However, IFN-gamma
receptor and trans-membrane signal transduction path
were apparently intact in HZ-fed monocytes, as indicated
by the normal phosphorylation of JAK-2 (Figure 2).
Effect of IFN-gamma and cytokine-LPS mix on NO 
production by immuno-purified human monocytes and 
murine phagocytic cell lines fed or not with HZ and sHZ
Stimulation by IFN-gamma (100 U/mL) or by the
cytokine-LPS mix did not increase NO production (meas-
ured as nitrite) in HZ- or sHZ-fed, haemin treated or
unfed control human monocytes (Figure 3A). By contrast,
murine RAW 264.7 macrophages treated with IFN-gamma
(100 U/mL) for 24 h showed a significant 4.1-fold
increase in the production of NO compared to untreated
controls. NO in the supernatant of IFN-gamma-treated
murine macrophages attained 23.4 nmoles/mg protein
(Figure 3B). Stimulation of HZ-fed or haemin-treated
murine macrophages with IFN-gamma (100 U/mL) fur-
ther enhanced NO production 6-fold and 2.6-fold, respec-
tively, compared to HZ-fed or haemin-treated but IFN-
gamma untreated cells (Figure 3B). Feeding with sHZ led
to lower IFN-gamma-mediated stimulation of NO pro-
duction compared to HZ. Remarkably, treatment of unfed
murine RAW 264.7 macrophages with the stimulatory
cytokine-LPS mix increased NO output up to 44.3-fold.
(Figure 3B). Similar results were obtained with murine
phagocytic lines ANA1 and N11 (results not shown).
Effect of IFN-gamma and cytokine-LPS mix on iNOS 
protein expression in immuno-purified human monocytes 
and murine phagocytic cell lines fed or not with HZ and 
sHZ
To detect even very low copy numbers of iNOS in human
monocyte lysates, iNOS was concentrated by immunopre-
cipitation before Western blot analysis. No iNOS was
detectable in HZ or sHZ fed or unfed human monocytes
even after enrichment or addition of the stimulatory
cytokine-LPS mix that strongly enhanced expression of
iNOS in murine RAW 264.7 macrophages, detectable
already without enrichment by immunoprecipitation
(Figure 4A and Figure 4B). Murine cells fed with sHZ were
less responsive compared to cells fed with native HZ.
Overall, there was a parallelism between protein expres-
sion and NO production (Figure 3B). Similar results were
obtained with murine phagocytic cell lines ANA1 and
N11 (results not shown).
HZ-fed immuno-purified human monocytes transmit the  IFN-gamma signal into the cell with subsequent JAK2 phos- phorylation Figure 2
HZ-fed immuno-purified human monocytes transmit 
the IFN-gamma signal into the cell with subsequent 
JAK2 phosphorylation. Adherent monocytes were fed or 
not with native P. falciparum HZ for 24 h. Phosphorylated 
JAK-2 from control and HZ-fed monocytes treated or not 
with IFN-gamma was immunoprecipitated with anti-phospho-
tyrosine and probed with anti-JAK-2 in Western blot. One 
representative experiments out of 3 with similar results.
Expression profiles of CD54 (A) and MHC class II (B) on  adherent immuno-purified human monocytes Figure 1
Expression profiles of CD54 (A) and MHC class II (B) 
on adherent immuno-purified human monocytes. 
One representative experiment shows the upregulation of 
cell surface antigenes by IFN-gamma (dotted line) or 
cytokine-LPS mix (solid thin line) 48 h after stimulation com-
pared to untreated controls (solid thick line) measured by 
flow cytometry. Background is plotted as solid area.Malaria Journal 2007, 6:73 http://www.malariajournal.com/content/6/1/73
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Effect of IFN-gamma and cytokine-LPS mix on iNOS 
mRNA expression in immuno-purified human monocytes 
and murine phagocytic cell lines fed or not with HZ and 
sHZ
Again, iNOS mRNA expression in human monocytes was
totally unresponsive to any stimulus applied (Figure 5A)
while in murine phagocytic cell lines IFN-gamma and the
stimulatory cytokine-LPS mix induced remarkable
increases in iNOS-specific mRNA levels detected by qual-
itative RT-PCR (data not shown) and confirmed by real-
time RT-PCR (Figure 5B). In murine RAW 264.7 macro-
phages, association of IFN-gamma treatment with phago-
cytosis of HZ or sHZ enhanced iNOS mRNA expression
35.2- and 15-fold, respectively. To exclude artefacts due to
unspecific effects of haemin possibly liberated in the
phagocytes from ingested sHZ, the effect of haemin on
iNOS mRNA expression was also checked, providing neg-
ative results in human monocytes and positive results in
murine cells (Figure 5A and Figure 5B). The quantitative
discrepancy between the modest iNOS mRNA induction
and the very high NO production elicited by haemin in
murine cells (Figure 3B), could be explained by the unspe-
cific reactivity of the Griess reagent with bilirubin pro-
duced by macrophages (E. Schwarzer, unpublished
observation). Very similar results were obtained with
murine phagocytic cell lines ANA1 and N11 (results not
shown).
Discussion
Human and murine phagocytic cell lines ingest large
amounts of HZ that upsets several functions connected
with modulation of immunity. HZ-laden human mono-
cytes were unable to kill ingested pathogens and produce
oxidative burst [26,27], did not upregulate MHC class II
and CD54 (ICAM-1) after IFN-gamma stimulation [15],
produced increased amounts of TNF-alpha and IL-1beta
[28] while HZ-laden human and murine monocytes were
severely impaired in their ability to differentiate and
mature to functional dendritic cells [29,30]. Recently,
phagocytosis of falciparum HZ and sHZ by murine phago-
cytes was shown to significantly increase IFN-gamma-
mediated iNOS expression and NO production [14].
Those data have prompted present work aimed to check
transferability of observations obtained with murine
phagocytes fed with human HZ to a fully human system
formed by immuno-purified human monocytes fed with
native falciparum HZ. A second aim was to validate the
role of HZ phagocytosis by monocytes as inducer of
increased iNOS expression and NO levels observed in
clinical malaria [31]. Present data obtained with HZ-fed
murine phagocytes as the target cells confirm results
NO production by (A) immuno-purified human monocytes  and (B) RAW264.7 murine macrophages Figure 3
NO production by (A) immuno-purified human 
monocytes and (B) RAW264.7 murine macrophages. 
Cells were fed or not with HZ or sHZ, or treated with hae-
min added as met-haem-albumin. A portion of the cells was 
additionally stimulated with IFN-gamma (100 U/mL) or a 
stimulatory cytokine-LPS mix (MIX+LPS) containing IFN-
gamma (400 U/mL), TNF-alpha (500 U/mL), IL-1beta (100 U/
mL) and LPS (20 µg/mL) (final concentrations). After 24 h 
incubation, NO production was measured as nitrite in the 
cell culture supernatants and expressed as nmole/mg cell 
protein. Mean values ± SE (n = 2–11). The difference 
between untreated/unfed controls and treated/fed cells was 
tested for significance:*p < 0.05; **p < 0.1.
iNOS protein expression in (A) immuno-purified human  monocytes and (B) RAW264.7 murine macrophages Figure 4
iNOS protein expression in (A) immuno-purified 
human monocytes and (B) RAW264.7 murine mac-
rophages. Cells were fed or not with HZ or sHZ. A portion 
of the cells was additionally stimulated with IFN-gamma (100 
U/ml) or a stimulatory cytokine-LPS mix (MIX+LPS) contain-
ing IFN-gamma (400 U/mL), TNF-alpha (500 U/mL), IL-1beta 
(100 U/mL) and LPS (20 µg/mL) (final concentrations). After 
24 h incubation cells were analysed for iNOS expression. 
Immune-precipitated iNOS from lysate proteins of human 
monocytes (A) or lysate proteins of RAW264.7 murine mac-
rophages (B) were separated by 10% SDS-PAGE and blotted 
to PVDF. iNOS was visualized via ECL by binding of a mono-
clonal anti-iNOS antibody. Recombinant iNOS (Sigma) was 
used as positive control. Blots shown are representative for 
five separate experiments.Malaria Journal 2007, 6:73 http://www.malariajournal.com/content/6/1/73
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obtained by Jaramillo et al. [14] with a similar experimen-
tal system. By contrast, no induction of iNOS protein or
mRNA expression, and no production of NO were
observed in HZ-fed immuno-purified human monocytes
even after maximal stimulation by an appropriate stimu-
latory cytokine-LPS mix. These negative results are in line
with studies indicating that human monocytes are unable
to express iNOS even after maximal cytokine/LSP stimula-
tion [3-5], but disagree with a number of other studies
[6,9,13,31]. Of note, present results were obtained with
immuno-purified monocytes while the vast majority of
data showing increased iNOS espression in malaria were
obtained with monocytes isolated by gradient centrifuga-
tion and adhesion to plastics. Present group's experience
indicates that the latter method produces monocytes
heavily contaminated with iNOS-expressing lymphocytes.
Apart from these methodological problems, there is no
general acceptance as to the importance of iNOS and NO
in malaria. For example, in a recent review [32], evidence
was summarized indicating that killing of Plasmodium by
NO in vivo is unlikely, protective role of NO controversial
and overproduction of NO not sufficiently supported. In
fact, at variance with studies in Africa [8,9] studies per-
formed in Papua New Guinea [33] found no relationship
between NO levels and parasitaemia either cross-section-
ally at baseline or comparing the same subjects during
parasitaemic and non-parasitaemic episodes. In those
studies, iNOS expression and activity in monocytes were
not related either to parasitaemia or to iNOS metabolite
levels [33]. Present data showing lack of response of iNOS
expression and NO production by stimulated HZ-fed
human monocytes, agree with this critical attitude, cast
serious doubt on the capacity of human monocytes to
generate NO, and suggest caution in the frequent extrapo-
lation to human malaria of data obtained with murine or
hybrid systems. Future studies performed with highly
purified blood monocytes will confirm or disprove avail-
able data on NO protection in malaria, and will clarify
whether different ethnic backgrounds (Africa vs Papua
New Guinea) may explain divergent iNOS expression and
modulation.
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